Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Adrenal Insufficiency × 90 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 139 Neoplasms 124 Carcinoma, Non-Small-Cell Lung 91 Prostatic Neoplasms 71 Colorectal Neoplasms 70 Lung Neoplasms 67 Multiple Myeloma 46 Leukemia, Myeloid, Acute 42 Neoplasm Metastasis 38 Carcinoma, Hepatocellular 35 Recurrence 34 Squamous Cell Carcinoma of Head and Neck 33 Ovarian Neoplasms 30 Brain Neoplasms 29 Precursor Cell Lymphoblastic Leukemia-Lymphoma 28 Stomach Neoplasms 27 Glioblastoma 27 Pancreatic Neoplasms 26 Glioma 26 Uterine Cervical Neoplasms 25 Rectal Neoplasms 24 Endometrial Neoplasms 24 Triple Negative Breast Neoplasms 22 Small Cell Lung Carcinoma 21 Colonic Neoplasms 20 Anxiety Disorders 20 Melanoma 19 Head and Neck Neoplasms 18 Carcinoma, Renal Cell 18 Motor Activity 17

Interventions

ravulizumab 1 Prednisone 1 Prednisolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07221838 2026-03-03

OCTAGON

Alexion Pharmaceuticals, Inc.

Phase 4 Not yet recruiting

Adrenal Insufficiency, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡